메뉴 건너뛰기




Volumn 65, Issue 12, 2009, Pages 1229-1235

Association between the use of anticholinergic antiparkinson drugs and safety and receptor drug-binding profiles of antipsychotic agents

Author keywords

Adverse effects; Anticholinergic agents; Antiparkinson agents; Antipsychotic agents; Extrapyramidal side effects

Indexed keywords

AMISULPRIDE; ATYPICAL ANTIPSYCHOTIC AGENT; BIPERIDEN; CHLORPROMAZINE; CHLORPROTHIXENE; CLOZAPINE; DIXYRAZINE; DOPAMINE 2 RECEPTOR; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; OLANZAPINE; ORPHENADRINE; PERPHENAZINE; PIMOZIDE; PROCHLORPERAZINE; QUETIAPINE; RISPERIDONE; SEROTONIN 2A RECEPTOR; THIORIDAZINE; ZIPRASIDONE; ZUCLOPENTHIXOL;

EID: 71249083955     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-009-0696-6     Document Type: Article
Times cited : (4)

References (24)
  • 1
    • 0034598111 scopus 로고    scopus 로고
    • Atypical antipsychotics in the treatment of schizophrenia: Systematic overview and meta-regression analysis
    • 10.1136/bmj.321.7273.1371 1:STN:280:DC%2BD3M7hsFSrsg%3D%3D 11099280
    • J Geddes N Freemantle P Farrison P Bebbington 2000 Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis BMJ 321 1371 1376 10.1136/bmj.321.7273.1371 1:STN:280:DC%2BD3M7hsFSrsg%3D%3D 11099280
    • (2000) BMJ , vol.321 , pp. 1371-1376
    • Geddes, J.1    Freemantle, N.2    Farrison, P.3    Bebbington, P.4
  • 2
    • 0038582771 scopus 로고    scopus 로고
    • New generation antipsychotics versus low-potency conventional antipsychotics: A systematic review and meta-analysis
    • DOI 10.1016/S0140-6736(03)13306-5
    • S Leucht K Wahlbeck J Hamann W Kissling 2003 New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis Lancet 361 1581 1589 10.1016/S0140-6736(03)13306-5 1:CAS:528:DC%2BD3sXjs1Wltbw%3D 12747876 (Pubitemid 36578993)
    • (2003) Lancet , vol.361 , Issue.9369 , pp. 1581-1589
    • Leucht, S.1    Wahlbeck, K.2    Hamann, J.3    Kissling, W.4
  • 3
    • 0038653525 scopus 로고    scopus 로고
    • A meta-analysis of the efficacy of second-generation antipsychotics
    • DOI 10.1001/archpsyc.60.6.553
    • JM Davis N Chen ID Glick 2003 A meta-analysis of the efficacy of second-generation antipsychotics Arc Gen Psychiatry 60 553 564 10.1001/archpsyc.60.6.553 1:CAS:528:DC%2BD3sXltlKhtrc%3D (Pubitemid 36682312)
    • (2003) Archives of General Psychiatry , vol.60 , Issue.6 , pp. 553-564
    • Davis, J.M.1    Chen, N.2    Glick, I.D.3
  • 6
    • 33749321169 scopus 로고    scopus 로고
    • Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)
    • DOI 10.1001/archpsyc.63.10.1079
    • PB Jones TRE Barnes L Davies G Dunn H Lloyd KP Hayhurst RM Murray A Markwick SW Lewis 2006 Randomized controlled trial of the effect on quality of life of second- vs. first-generation antipsychotic drugs in schizophrenia Arch Gen Psychiatry 63 1079 1087 10.1001/archpsyc.63.10.1079 1:CAS:528: DC%2BD28XhtFKhtrzP 17015810 (Pubitemid 44498387)
    • (2006) Archives of General Psychiatry , vol.63 , Issue.10 , pp. 1079-1087
    • Jones, P.B.1    Barnes, T.R.E.2    Davies, L.3    Dunn, G.4    Lloyd, H.5    Hayhurst, K.P.6    Murray, R.M.7    Markwick, A.8    Lewis, S.W.9
  • 7
    • 33745875644 scopus 로고    scopus 로고
    • Haloperidol dose when used as active comparator in randomized controlled trials with atypical antipsychotics in schizophrenia: Comparison with officially recommended doses
    • 1:CAS:528:DC%2BD28XnsVamsrs%3D 16848649
    • GWK Hugenholtz ER Heerdink JJ Stolker WEE Meijer ACG Egberts WA Nolen 2006 Haloperidol dose when used as active comparator in randomized controlled trials with atypical antipsychotics in schizophrenia: comparison with officially recommended doses J Clin Psychiatry 67 897 903 1:CAS:528:DC%2BD28XnsVamsrs%3D 16848649
    • (2006) J Clin Psychiatry , vol.67 , pp. 897-903
    • Hugenholtz, G.W.K.1    Heerdink, E.R.2    Stolker, J.J.3    Meijer, W.E.E.4    Egberts, A.C.G.5    Nolen, W.A.6
  • 8
    • 33645105012 scopus 로고    scopus 로고
    • Serotonin-dopamine antagonists (atypical or second-generation antipsychotics)
    • J.B. Sadock V.A. Sadock (eds). Lippincott Williams & Wilkins Philadelphia
    • van Kammen DP, Marder SR (2005) Serotonin-dopamine antagonists (atypical or second-generation antipsychotics). In: Sadock JB, Sadock VA (eds) Kaplan & Sadock's comprehensive textbook of psychiatry. Lippincott Williams & Wilkins, Philadelphia, pp 2914-2938
    • (2005) Kaplan & Sadock's Comprehensive Textbook of Psychiatry , pp. 2914-2938
    • Van Kammen, D.P.1    Marder, S.R.2
  • 10
    • 61349156022 scopus 로고    scopus 로고
    • The use and potential abuse of anticholinergic antiparkinson drugs in Norway. A pharmacoepidemiological study
    • 10.1111/j.1365-2125.2008.03342.x 19094158
    • P Gjerden JG Bramness L Slørdal 2008 The use and potential abuse of anticholinergic antiparkinson drugs in Norway. A pharmacoepidemiological study Br J Clin Pharmacol 67 2 228 233 10.1111/j.1365-2125.2008.03342.x 19094158
    • (2008) Br J Clin Pharmacol , vol.67 , Issue.2 , pp. 228-233
    • Gjerden, P.1    Bramness, J.G.2    Slørdal, L.3
  • 11
    • 34447320942 scopus 로고    scopus 로고
    • The Norwegian Prescription Database (NorPD): New register for pharmacoepidemiological research covering a whole nation
    • K Furu H Strøm M Rønning S Skurtveit A Engedal A Tverdal 2005 The Norwegian Prescription Database (NorPD): new register for pharmacoepidemiological research covering a whole nation Pharmacoepidemiol Drug Saf 14 Suppl 2 S48
    • (2005) Pharmacoepidemiol Drug Saf , vol.14 , Issue.SUPPL 2 , pp. 48
    • Furu, K.1    Strøm, H.2    Rønning, M.3    Skurtveit, S.4    Engedal, A.5    Tverdal, A.6
  • 12
    • 0004100812 scopus 로고    scopus 로고
    • WHO Collaborating Centre for Drug Statistics Methodology. WHO Oslo
    • WHO Collaborating Centre for Drug Statistics Methodology (2005) Guidelines for ATC classification and DDD assignment. WHO, Oslo
    • (2005) Guidelines for ATC Classification and DDD Assignment
  • 15
    • 0025268175 scopus 로고
    • Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment. A consensus statement. World Health Organization heads of centres collaborating in WHO co-ordinated studies on aspects of mental illness
    • Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment. A consensus statement. World Health Organization heads of centres collaborating in WHO co-ordinated studies on aspects of mental illness (1990) Br J Psychiatry 156:412
    • (1990) Br J Psychiatry , vol.156 , pp. 412
  • 16
    • 64549134700 scopus 로고    scopus 로고
    • Effect of warnings in a medical journal on the use of orphenadrine
    • 10.1111/j.1365-2753.2007.00912.x 18462287
    • P Gjerden JG Bramness L Slørdal 2008 Effect of warnings in a medical journal on the use of orphenadrine J Eval Clin Pract 14 615 617 10.1111/j.1365-2753.2007.00912.x 18462287
    • (2008) J Eval Clin Pract , vol.14 , pp. 615-617
    • Gjerden, P.1    Bramness, J.G.2    Slørdal, L.3
  • 18
    • 23744432102 scopus 로고    scopus 로고
    • Effect of switching antipsychotics on antiparkinsonian medication use in schizophrenia: Population-based study
    • DOI 10.1192/bjp.187.2.137
    • S Park D Ross-Degnan AS Adams J Sabin P Kanavos SB Soumerai 2005 Effect of switching antipsychotics on antiparkinsonian medication use in schizophrenia Br J Psychiatry 187 137 142 10.1192/bjp.187.2.137 16055824 (Pubitemid 41139685)
    • (2005) British Journal of Psychiatry , vol.187 , Issue.AUG. , pp. 137-142
    • Park, S.1    Ross-Degnan, D.2    Adams, A.S.3    Sabin, J.4    Kanavos, P.5    Soumerai, S.B.6
  • 19
    • 40949136198 scopus 로고    scopus 로고
    • Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia. A systematic review
    • 10.1097/JCP.0b013e318166c4d5
    • K Gao DE Kemp SJ Ganocy P Gajwani G Xia JR Calabrese 2008 Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia. A systematic review J Clin Psychopharm 28 203 209 10.1097/JCP.0b013e318166c4d5
    • (2008) J Clin Psychopharm , vol.28 , pp. 203-209
    • Gao, K.1    Kemp, D.E.2    Ganocy, S.J.3    Gajwani, P.4    Xia, G.5    Calabrese, J.R.6
  • 20
    • 0034116158 scopus 로고    scopus 로고
    • Prevalence of spontaneous dyskinesia in schizophrenia
    • 10739325
    • WS Fenton 2000 Prevalence of spontaneous dyskinesia in schizophrenia J Clin Psychiatry 61 Suppl 4 10 14 10739325
    • (2000) J Clin Psychiatry , vol.61 , Issue.SUPPL 4 , pp. 10-14
    • Fenton, W.S.1
  • 21
    • 18844449208 scopus 로고    scopus 로고
    • Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness
    • DOI 10.1177/0269881105051539
    • WG Honer LC Kopala J Rabinowitz 2005 Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness J Psychopharmacol 19 3 277 285 10.1177/0269881105051539 1:CAS:528:DC%2BD2MXltlWju74%3D 15888513 (Pubitemid 40694946)
    • (2005) Journal of Psychopharmacology , vol.19 , Issue.3 , pp. 277-285
    • Honer, W.G.1    Kopala, L.C.2    Rabinowitz, J.3
  • 23
    • 50849107618 scopus 로고    scopus 로고
    • How CATIE brought us back to Kansas: A critical re-evaluation of the concept of atypical antipsychotics and their place in the treatment of schizophrenia
    • 10.1192/apt.bp.107.003970
    • DC Owens 2008 How CATIE brought us back to Kansas: a critical re-evaluation of the concept of atypical antipsychotics and their place in the treatment of schizophrenia Adv Psychiatr Treat 14 17 28 10.1192/apt.bp.107. 003970
    • (2008) Adv Psychiatr Treat , vol.14 , pp. 17-28
    • Owens, D.C.1
  • 24
    • 58049157203 scopus 로고    scopus 로고
    • Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis
    • 10.1016/S0140-6736(08)61764-X 1:CAS:528:DC%2BD1MXht1Wqsw%3D%3D 19058842
    • S Leucht C Corves D Arbter RR Engel C Li JM Davis 2009 Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis Lancet 373 31 41 10.1016/S0140-6736(08)61764-X 1:CAS:528:DC%2BD1MXht1Wqsw%3D%3D 19058842
    • (2009) Lancet , vol.373 , pp. 31-41
    • Leucht, S.1    Corves, C.2    Arbter, D.3    Engel, R.R.4    Li, C.5    Davis, J.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.